Huge win for patients as three pathology items added to Medicare Benefits Schedule following RCPA applications to MSAC
18 November, 2021

This month, three new items will be added to the Medicare Benefits Schedule (MBS) following several applications by the Royal College of Pathologists of Australasia (RCPA) to the Medical Services Advisory Committee (MSAC). The items include genetic testing for certain blood cell cancers and for pregnancies with major fetal structural abnormalities, and diagnostic testing for neuromyelitis (NMO). It is expected that these additions will improve access to life changing pathology services for approximately 22-23,000 patients per year.

Go Back

Page last updated:

Copyright © 2022 RCPA. All rights reserved.